Last March, a PhD student at Harvard filed a misconduct allegation against his mentor, a prominent stem cell researcher. Three months later, he was taken from his home by police in the middle of the night for a forced psychiatric evaluation.
How did this happen? Continue reading A Harvard whistleblower was subjected to a forced mental exam. Here’s why.
Nearly five years ago, researchers suggested that the vast majority of preclinical cancer research wouldn’t hold up to follow-up experiments, delaying much needed treatments for patients. In a series of articles publishing tomorrow morning, eLife has released the results of the first five attempts to replicate experiments in cancer biology — and the results are decidedly mixed.
As our co-founders Adam Marcus and Ivan Oransky write in STAT, the overall take-home message was that two studies generated findings similar to the original, one did not replicate the original, and two others were inconclusive.
They quote Brian Nosek, a psychologist at the University of Virginia, in Charlottesville, who runs the Center for Open Science, who has been leading the replication effort in his own field:
Continue reading At last, cancer reproducibility project releases some results — and they’re mixed
Last year, Pfizer fired one of its scientists following an investigation that ended with requests for retraction of five of her studies. Now, two of the five papers, which were first flagged on PubPeer, have been retracted.
One notice cites the Pfizer investigation, which found that cancer researcher Min-Jean Yin had included duplicated images in all five papers. Yin is the last author on both retracted papers.
Here’s the first notice from Clinical Cancer Research, which says most or all of the questioned images appear to be duplicates, and Pfizer — who sponsored the study and requested the retraction — can’t find the originals:
Continue reading Breast cancer studies by fired Pfizer employee retracted
A 2016 study was retracted from a Frontiers journal after editors realized the authors had omitted experiments that didn’t support the hypothesis.
Gearóid Ó Faoleán, ethics and integrity manager at Frontiers, which publishes Frontiers in Plant Science, told us:
In accordance with our complaints protocol, the Field Chief Editor led the investigation that resulted in the decision to retract the paper.
Here’s the retraction notice: Continue reading “Crucial experiments” missing from retracted plant study
Researchers in China have retracted two 2016 papers about the possible use of a cholesterol-lowering agent to treat bleeding on the brain.
One of the retracted papers in the Journal of Neurosurgery (JNS) had multiple problems that were “too extensive to revise,” according to the lengthy retraction notice, relating to issues with authorship, data analyses, and patient enrollment. The notice is signed by first author Hua Liu of the Nanjing Medical University in China.
Liu is also the first author of another recently retracted paper in Frontiers in Neuroscience, pulled for incorrectly categorizing patients.
The JNS retraction notice begins: Continue reading Authors retract two statin papers, one with problems “too extensive to revise”
An oncology journal has decided to retract a 2012 paper on gastric cancer after discovering duplicated data in multiple figures.
According to the retraction notice, the journal’s editorial board received a tip from a reader regarding the potential figure issues. Oncology Reports launched an investigation, which confirmed the allegations. The authors failed to respond to the journal’s multiple requests for more information.
Here’s the retraction notice: Continue reading Journal retracts gastric cancer study with multiple duplications, authors MIA
In 2011, authors of a Nature letter caught some flak for issuing a lengthy correction to a neuroscience paper that had raised eyebrows within days of publication — including some suggestions it should be retracted.
The correction notice, published months after the original letter, cited errors in image choice and labeling, but asserted the conclusions remained valid.
Now, those conclusions appear up for debate. In a recent Nature Brief Communications Arising (BCA) article, a team that raised concerns about the paper five years ago says they are unable to reproduce the results. But the authors of the original paper aren’t convinced: They argue that the BCA fails to cite important evidence, has a “complete absence or low quality of analysis,” and the scientists disregard some of their data.
Continue reading Nature paper with massive correction can’t be reproduced, says independent group
A scientist in Ireland has corrected five of his papers in a single journal dating back more than a decade, after image-related problems were brought to his attention.
Four of the newly corrected papers have a common last and corresponding author: Luke O’Neill of Trinity College Dublin in the Republic of Ireland. O’Neill is also a co-author of the remaining paper that was fixed. O’Neill told us the mistakes were a “bit sloppy,” noting that he takes responsibility for the errors in the four papers on which he is last author.
O’Neill forwarded Retraction Watch a comment he received from Kaoru Sakabe — data integrity manager at the American Society for Biochemistry and Molecular Biology (which publishes The Journal of Biological Chemistry (JBC)) — that reads:
Continue reading “An example for all authors to uphold:” Researcher logs 5 corrections
A journal has issued an expression of concern (EOC) for a recently published study after a probe identified “problems with the figure presentation.”
According to the EOC notice in New Phytologist, two figures in the paper contained “some anomalies,” and the corresponding author has acknowledged that there are problems with the images.
Here’s the EOC notice: Continue reading Plant journal flags fungus paper amid investigation
After researchers in China included the same images in two papers published online one month apart, one paper has been retracted, and the other flagged with an expression of concern.
According to the retraction notice in the International Journal of Molecular Medicine (IJMM), the authors intended that the two different papers offered “different research perspectives.”
Meanwhile, the Chinese Medical Journal — which published the same images one month later — has issued an expression of concern (EOC), noting it “should not be considered as a statement regarding the validity of the work.” Both papers describe how cells regulate blood flow to the retina.
Normally, journals choose to retract the most recent paper containing duplicated images, but in this case, the IJMM paper was published online in February 2016, and the Chinese Medical Journal in March.
Here’s the retraction notice: Continue reading Authors use same images in two studies — one is retracted, the other flagged by journal